Literature DB >> 20337852

Profound cardiac conduction delay predicts mortality in myotonic dystrophy type 1.

S Mörner1, P Lindqvist, C Mellberg, B-O Olofsson, C Backman, M Henein, D Lundblad, H Forsberg.   

Abstract

BACKGROUND: Myotonic dystrophy type 1 (DM1) is known to affect mainly the musculoskeletal system. Early mortality is related to respiratory disease and possibly additional cardiovascular complications. AIMS: To identify possible cardiovascular disturbances that could predict survival of DM1 patients.
METHODS: We studied 30 DM1 patients (mean age 41 +/- 13.5 years, range 16-71, 15 women) who were cardiovascularly stable and compared them with 29 controls (mean age 55 +/- 7.8 years, range 42-66, 14 women) using electrocardiography (ECG) and conventional transthoracic echocardiography. The subgroup that survived a follow-up period of 17 years was re-examined using the same protocol.
RESULTS: Of the 30 patients, 10 died of a documented respiratory cause and three of acute myocardial incidents. Compared with controls, left ventricular cavity size, corrected to body surface area, was slightly enlarged at end systole (P < 0.05) and hence fractional shortening was reduced (P < 0.01). Nine patients had first-degree heart block and 15 had a QRS duration >90 ms. Of all ECG and echocardiographic measurements, the sum of QRS duration + PR interval was the best predictor of mortality as shown by the area under the receiver operating characteristic curve of 85%, sensitivity of 70% and specificity of 84%.
CONCLUSIONS: These findings suggest that silent cardiac dysfunction in DM1 patients may cause significant disturbances that over time result in serious complications. Regular follow-up of such patients with detailed electrical and mechanical cardiac assessment may suggest a need for early intervention that may avoid early mortality in some.

Entities:  

Mesh:

Year:  2010        PMID: 20337852     DOI: 10.1111/j.1365-2796.2010.02213.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

Review 1.  Mechanisms and management of the heart in myotonic dystrophy.

Authors:  Elizabeth M McNally; Dina Sparano
Journal:  Heart       Date:  2011-07       Impact factor: 5.994

2.  The evolution of infrahissian conduction time in myotonic dystrophy patients: clinical implications.

Authors:  Bénédicte Lallemand; Nicolas Clementy; Anne Bernard-Brunet; Bertrand Pierre; Philippe Corcia; Laurent Fauchier; Martine Raynaud; Sybille Pellieux; Dominique Babuty
Journal:  Heart       Date:  2011-10-29       Impact factor: 5.994

3.  Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy.

Authors:  Jongkyu Choi; Donald M Dixon; Warunee Dansithong; Walid F Abdallah; Kenneth P Roos; Maria C Jordan; Brandon Trac; Han Shin Lee; Lucio Comai; Sita Reddy
Journal:  Sci Rep       Date:  2016-08-03       Impact factor: 4.379

4.  Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.

Authors:  Mark J Hamilton; Yvonne Robb; Sarah Cumming; Helen Gregory; Alexis Duncan; Monika Rahman; Anne McKeown; Catherine McWilliam; John Dean; Alison Wilcox; Maria E Farrugia; Anneli Cooper; Josephine McGhie; Berit Adam; Richard Petty; Cheryl Longman; Iain Findlay; Alan Japp; Darren G Monckton; Martin A Denvir
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

Review 5.  The heart and cardiac pacing in Steinert disease.

Authors:  Gerardo Nigro; Andrea Antonio Papa; Luisa Politano
Journal:  Acta Myol       Date:  2012-10

6.  Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms.

Authors:  Donald M Dixon; Jongkyu Choi; Ayea El-Ghazali; Sun Young Park; Kenneth P Roos; Maria C Jordan; Michael C Fishbein; Lucio Comai; Sita Reddy
Journal:  Sci Rep       Date:  2015-03-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.